The RET fusion market, a pivotal segment within the oncology landscape, has been gaining considerable attention due to its implications in targeted cancer therapies. This article provides an in-depth forecast of the RET fusion market, examining current trends, ongoing clinical trials, and future projections. With the rapid advancements in molecular oncology, understanding the dynamics of the...